CN105085369B - A kind of aryl oxidized indole derivatives of 3- and its synthetic method - Google Patents
A kind of aryl oxidized indole derivatives of 3- and its synthetic method Download PDFInfo
- Publication number
- CN105085369B CN105085369B CN201410205509.XA CN201410205509A CN105085369B CN 105085369 B CN105085369 B CN 105085369B CN 201410205509 A CN201410205509 A CN 201410205509A CN 105085369 B CN105085369 B CN 105085369B
- Authority
- CN
- China
- Prior art keywords
- reaction
- nmr
- acid
- diazoindole
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000010189 synthetic method Methods 0.000 title abstract description 5
- 125000003118 aryl group Chemical group 0.000 title abstract 3
- 150000002475 indoles Chemical class 0.000 title abstract 3
- 229940054051 antipsychotic indole derivative Drugs 0.000 title description 2
- 238000006243 chemical reaction Methods 0.000 claims abstract description 60
- 238000000034 method Methods 0.000 claims abstract description 18
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000003054 catalyst Substances 0.000 claims abstract description 7
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 87
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 72
- 239000000047 product Substances 0.000 claims description 56
- 239000000243 solution Substances 0.000 claims description 56
- 238000003756 stirring Methods 0.000 claims description 48
- 239000007787 solid Substances 0.000 claims description 47
- -1 hydrogen Chemical class 0.000 claims description 40
- 239000002904 solvent Substances 0.000 claims description 30
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 29
- 238000004440 column chromatography Methods 0.000 claims description 24
- 239000012043 crude product Substances 0.000 claims description 24
- 239000003208 petroleum Substances 0.000 claims description 24
- 230000002829 reductive effect Effects 0.000 claims description 24
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 18
- 239000011259 mixed solution Substances 0.000 claims description 16
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical group OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 claims description 13
- 239000003377 acid catalyst Substances 0.000 claims description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 6
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims description 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 5
- 229910052794 bromium Inorganic materials 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 5
- 239000000460 chlorine Substances 0.000 claims description 5
- CPPKAGUPTKIMNP-UHFFFAOYSA-N cyanogen fluoride Chemical compound FC#N CPPKAGUPTKIMNP-UHFFFAOYSA-N 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 125000001624 naphthyl group Chemical group 0.000 claims description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 239000003480 eluent Substances 0.000 claims description 3
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 3
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 238000005580 one pot reaction Methods 0.000 claims description 3
- 230000002194 synthesizing effect Effects 0.000 claims description 3
- RILZRCJGXSFXNE-UHFFFAOYSA-N 2-[4-(trifluoromethoxy)phenyl]ethanol Chemical compound OCCC1=CC=C(OC(F)(F)F)C=C1 RILZRCJGXSFXNE-UHFFFAOYSA-N 0.000 claims description 2
- PCKPVGOLPKLUHR-UHFFFAOYSA-N OH-Indolxyl Natural products C1=CC=C2C(O)=CNC2=C1 PCKPVGOLPKLUHR-UHFFFAOYSA-N 0.000 claims description 2
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 claims description 2
- 238000001308 synthesis method Methods 0.000 claims description 2
- JUWOBCNAWKDBSM-UHFFFAOYSA-N 3-diazonio-1h-indol-2-olate Chemical compound C1=CC=C2C([N+]#N)=C([O-])NC2=C1 JUWOBCNAWKDBSM-UHFFFAOYSA-N 0.000 claims 3
- GURJQHUTWUWLQT-UHFFFAOYSA-N (3Z)-3-diazo-1H-indol-2-one Chemical compound C1=CC=C2C(=[N+]=[N-])C(=O)NC2=C1 GURJQHUTWUWLQT-UHFFFAOYSA-N 0.000 claims 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 claims 1
- 125000005561 phenanthryl group Chemical group 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 229910052723 transition metal Inorganic materials 0.000 abstract description 4
- 150000003624 transition metals Chemical class 0.000 abstract description 4
- 239000002699 waste material Substances 0.000 abstract description 3
- 239000007848 Bronsted acid Substances 0.000 abstract 1
- 239000012954 diazonium Substances 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-O diazynium Chemical compound [NH+]#N IJGRMHOSHXDMSA-UHFFFAOYSA-O 0.000 abstract 1
- 238000005481 NMR spectroscopy Methods 0.000 description 64
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 42
- PFBMPBURXWDAMJ-UHFFFAOYSA-N 3-diazoindole Chemical compound [N+](=[N-])=C1C=NC2=CC=CC=C12 PFBMPBURXWDAMJ-UHFFFAOYSA-N 0.000 description 36
- 238000010586 diagram Methods 0.000 description 32
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 24
- 238000010791 quenching Methods 0.000 description 23
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 21
- 235000017557 sodium bicarbonate Nutrition 0.000 description 21
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 11
- XPDWGBQVDMORPB-UHFFFAOYSA-N Fluoroform Chemical compound FC(F)F XPDWGBQVDMORPB-UHFFFAOYSA-N 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- 125000002541 furyl group Chemical group 0.000 description 8
- 125000001544 thienyl group Chemical group 0.000 description 8
- 125000000217 alkyl group Chemical group 0.000 description 6
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 125000003545 alkoxy group Chemical group 0.000 description 4
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 4
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 4
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- 239000011630 iodine Chemical group 0.000 description 4
- 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 4
- ULYONBAOIMCNEH-HNNXBMFYSA-N (3s)-3-(5-chloro-2-methoxyphenyl)-3-fluoro-6-(trifluoromethyl)-1h-indol-2-one Chemical compound COC1=CC=C(Cl)C=C1[C@@]1(F)C2=CC=C(C(F)(F)F)C=C2NC1=O ULYONBAOIMCNEH-HNNXBMFYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical class C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- RRSDYHBCICNUFM-UHFFFAOYSA-N 3-(5-chloro-2-methoxyphenyl)-6-(trifluoromethyl)-1,3-dihydroindol-2-one Chemical compound COC1=CC=C(Cl)C=C1C1C2=CC=C(C(F)(F)F)C=C2NC1=O RRSDYHBCICNUFM-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- FZERHIULMFGESH-UHFFFAOYSA-N N-phenylacetamide Chemical compound CC(=O)NC1=CC=CC=C1 FZERHIULMFGESH-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical class C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical class C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical class C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- JYGFTBXVXVMTGB-UHFFFAOYSA-N indolin-2-one Chemical compound C1=CC=C2NC(=O)CC2=C1 JYGFTBXVXVMTGB-UHFFFAOYSA-N 0.000 description 2
- JXDYKVIHCLTXOP-UHFFFAOYSA-N isatin Chemical compound C1=CC=C2C(=O)C(=O)NC2=C1 JXDYKVIHCLTXOP-UHFFFAOYSA-N 0.000 description 2
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical class C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Chemical group O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 2
- YSSPGXCFFITNCE-OAQYLSRUSA-N (3s)-3-(2-chlorophenyl)-1-[2-(diethylamino)ethyl]-3-hydroxy-2-oxo-4-(trifluoromethyl)indole-6-carboxamide Chemical compound C1([C@]2(O)C(=O)N(C3=C2C(=CC(=C3)C(N)=O)C(F)(F)F)CCN(CC)CC)=CC=CC=C1Cl YSSPGXCFFITNCE-OAQYLSRUSA-N 0.000 description 1
- KJDCXHPSSXVNER-UHFFFAOYSA-N 1-benzyl-3-(4-methoxyphenyl)-3H-indol-2-one Chemical compound C(C1=CC=CC=C1)N1C(C(C2=CC=CC=C12)C1=CC=C(C=C1)OC)=O KJDCXHPSSXVNER-UHFFFAOYSA-N 0.000 description 1
- YRGAYAGBVIXNAQ-UHFFFAOYSA-N 1-chloro-4-methoxybenzene Chemical compound COC1=CC=C(Cl)C=C1 YRGAYAGBVIXNAQ-UHFFFAOYSA-N 0.000 description 1
- VJBCCGJTLWKDGF-UHFFFAOYSA-N 1-methyl-3-(4-methylphenyl)-3H-indol-2-one Chemical compound C12=CC=CC=C2N(C)C(=O)C1C1=CC=C(C)C=C1 VJBCCGJTLWKDGF-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- DPVWJPVYOXKFRQ-BDMNMGLZSA-N Hodgkinsine Chemical compound N([C@H]1N(C)CC2)C3=CC=CC=C3[C@@]12[C@@]12CCN(C)[C@H]2NC2=C1C=CC=C2[C@@]12CCN(C)[C@H]2NC2=CC=CC=C12 DPVWJPVYOXKFRQ-BDMNMGLZSA-N 0.000 description 1
- DPVWJPVYOXKFRQ-UHFFFAOYSA-N Hodgkinsine Natural products C1CN(C)C2NC3=CC=CC=C3C21C12CCN(C)C2NC2=C1C=CC=C2C12CCN(C)C2NC2=CC=CC=C12 DPVWJPVYOXKFRQ-UHFFFAOYSA-N 0.000 description 1
- 238000006898 Intramolecular Friedel-Crafts reaction Methods 0.000 description 1
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 229960001413 acetanilide Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical class CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000002894 chemical waste Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000003682 fluorination reaction Methods 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 150000002476 indolines Chemical class 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 1
- 238000003541 multi-stage reaction Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 150000005623 oxindoles Chemical class 0.000 description 1
- 238000003431 reductive deoxygenation reaction Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 229930192474 thiophene Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Indole Compounds (AREA)
Abstract
Description
技术领域technical field
本发明涉及合成医药、化工领域,主要涉及一种快速、绿色的对3-芳基氧化吲哚衍生物及其化学合成方法。The invention relates to the fields of synthetic medicine and chemical industry, and mainly relates to a rapid and green p-3-aryloxindole derivative and a chemical synthesis method thereof.
背景技术Background technique
3-芳基氧化吲哚广泛用于3,3-双取代氧化吲哚和吲哚啉的合成,而3,3-双取代氧化吲哚和吲哚啉是一系列生物活性天然产物和合成药物的骨架结构,例如SM-130686、BMS-204352、hodgkinsine、qudrigemine C等(如下所示)。在过去的几十年中已经发展了一系列的3-芳基氧化吲哚的合成方法,如由α-卤代乙酰胺出发的强酸促进的分子内傅克反应、强碱或光照促进的分子内环化反应、二价钯催化的分子内偶联反应;由格氏试剂对靛红加成然后再经路易斯酸催化的还原脱氧反应;二价钯催化的吲哚酮与芳香卤代物的分子间偶联反应;3-重氮氧化吲哚与芳基硼试剂的偶联反应。但是,以上方法存在着反应条件苛刻、使用空气敏感的试剂或者过渡金属催化剂、大多涉及到多步反应因而中间过程会产生大量的化学废弃物,而且耗时长、成本高等缺陷,因此上述方法都不利于3-芳基氧化吲哚在有机合成中的应用及其工业化合成。3-Aryloxindoles are widely used in the synthesis of 3,3-disubstituted oxindoles and indolines, which are a series of biologically active natural products and synthetic drugs The skeleton structure of such as SM-130686, BMS-204352, hodgkinsine, qudrigemine C, etc. (as shown below). A series of synthetic methods for 3-aryloxindoles have been developed in the past decades, such as strong acid-promoted intramolecular Friedel-Crafts reactions starting from α-haloacetamides, strong bases or light-promoted molecules Internal cyclization reaction, intramolecular coupling reaction catalyzed by divalent palladium; addition of isatin by Grignard reagent and then reductive deoxygenation reaction catalyzed by Lewis acid; molecule of indolinone and aromatic halide catalyzed by divalent palladium Intercoupling reaction; Coupling reaction of 3-diazoindole with arylboron reagent. However, the above methods have defects such as harsh reaction conditions, use of air-sensitive reagents or transition metal catalysts, and mostly involve multi-step reactions, which will generate a large amount of chemical waste in the intermediate process, and are time-consuming and costly. It is beneficial to the application of 3-aryloxindole in organic synthesis and its industrial synthesis.
含3-芳基氧化吲哚结构单元的生物活性分子Biologically Active Molecules Containing 3-Aryloxindole Structural Units
发明内容Contents of the invention
本发明克服现有技术的上述缺陷,公开一种制备路线短,反应可靠、操作简单的3-芳基氧化吲哚的合成方法。本发明设计了以3-重氮氧化吲哚与芳烃为原料、只经一步反应就制备得到3-芳基氧化吲哚的方法。相比于已报道的合成方法,本方法具有避免使用昂贵的过渡金属催化剂、以廉价易得的芳烃为原料、反应条件温和、反应步骤少、反应快、成本低、产生的废物少、原子经济性高等特点,因此该方法在药物合成领域具有很广阔的应用前景。The invention overcomes the above-mentioned defects of the prior art, and discloses a synthesis method of 3-aryloxindole with short preparation route, reliable reaction and simple operation. The present invention designs a method for preparing 3-aryloxindole by using 3-diazoindole and aromatic hydrocarbon as raw materials and only one-step reaction. Compared with the reported synthetic methods, this method has the advantages of avoiding the use of expensive transition metal catalysts, using cheap and easily available aromatic hydrocarbons as raw materials, mild reaction conditions, fewer reaction steps, fast reaction, low cost, less waste generated, atom economy Therefore, this method has broad application prospects in the field of drug synthesis.
本发明提出的3-芳基氧化吲哚衍生物,如以下式(I)所示,The 3-aryloxindole derivatives proposed by the present invention are as shown in the following formula (I):
其中,in,
R1为氢、烷基、烷氧羰基、酰基;R is hydrogen, alkyl, alkoxycarbonyl, acyl ;
R2为烷基、烷氧基、羟基、硝基、氰基、氟、氯、溴、碘; R is alkyl, alkoxy, hydroxyl, nitro, cyano, fluorine, chlorine, bromine, iodine;
Ar为苯基、取代苯基、呋喃基、取代呋喃基、噻吩基、取代噻吩基、苯并呋喃基、苯并噻吩基、萘基、蒽基、菲基。Ar is phenyl, substituted phenyl, furyl, substituted furyl, thienyl, substituted thienyl, benzofuryl, benzothienyl, naphthyl, anthracenyl, or phenanthrenyl.
其中,优选的,Among them, preferably,
R1为氢、苄基、甲基、烯丙基、苄氧羰基、甲氧羰基、乙氧羰基、甲酰基、乙酰基、苯甲酰基; R is hydrogen, benzyl, methyl, allyl, benzyloxycarbonyl, methoxycarbonyl, ethoxycarbonyl, formyl, acetyl, benzoyl;
R2为烷基、烷氧基、羟基、硝基、氰基、氟、氯、溴、碘; R is alkyl, alkoxy, hydroxyl, nitro, cyano, fluorine, chlorine, bromine, iodine;
Ar为苯基、取代苯基、呋喃基、取代呋喃基、噻吩基、取代噻吩基、苯并呋喃基、苯并噻吩基、萘基、蒽基、菲基。Ar is phenyl, substituted phenyl, furyl, substituted furyl, thienyl, substituted thienyl, benzofuryl, benzothienyl, naphthyl, anthracenyl, or phenanthrenyl.
本发明提出一种3-芳基氧化吲哚衍生物的合成方法,以3-重氮氧化吲哚和芳烃为原料,以质子酸为催化剂,经过一步反应制得3-芳基氧化吲哚,其反应方程式如式(A)所示:The present invention proposes a method for synthesizing 3-aryl indole derivatives, using 3-diazoindole and aromatic hydrocarbons as raw materials and using protonic acid as a catalyst to prepare 3-aryl indole through one-step reaction. Its reaction equation is as shown in formula (A):
其中,in,
R1为氢、烷基、烷氧羰基、酰基;R is hydrogen, alkyl, alkoxycarbonyl, acyl ;
R2为烷基、烷氧基、羟基、硝基、氰基、氟、氯、溴、碘; R is alkyl, alkoxy, hydroxyl, nitro, cyano, fluorine, chlorine, bromine, iodine;
Ar为苯基、取代苯基、呋喃基、取代呋喃基、噻吩基、取代噻吩基、苯并呋喃基、苯并噻吩基、萘基、蒽基、菲基。Ar is phenyl, substituted phenyl, furyl, substituted furyl, thienyl, substituted thienyl, benzofuryl, benzothienyl, naphthyl, anthracenyl, or phenanthrenyl.
其中,优选的,Among them, preferably,
R1为氢、苄基、甲基、烯丙基、苄氧羰基、甲氧羰基、乙氧羰基、甲酰基、乙酰基、苯甲酰基; R is hydrogen, benzyl, methyl, allyl, benzyloxycarbonyl, methoxycarbonyl, ethoxycarbonyl, formyl, acetyl, benzoyl;
R2为烷基、烷氧基、羟基、硝基、氰基、氟、氯、溴、碘; R is alkyl, alkoxy, hydroxyl, nitro, cyano, fluorine, chlorine, bromine, iodine;
Ar为苯基、取代苯基、呋喃基、取代呋喃基、噻吩基、取代噻吩基、苯并呋喃基、苯并噻吩基、萘基、蒽基、菲基。Ar is phenyl, substituted phenyl, furyl, substituted furyl, thienyl, substituted thienyl, benzofuryl, benzothienyl, naphthyl, anthracenyl, or phenanthrenyl.
本发明方法中,将所述芳烃和所述质子酸催化剂溶解于溶剂中,在0℃下,将3-重氮氧化吲哚的溶液缓缓加入到所述芳烃和质子酸催化剂的混合溶液中,同时剧烈搅拌;3-重氮氧化吲哚滴加完毕后,在室温下继续搅拌10~60分钟,直至3-重氮氧化吲哚消耗完全;然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(以乙酸乙酯:石油醚=1:30~1:10为洗脱剂)得到纯产品。In the method of the present invention, the aromatic hydrocarbon and the protonic acid catalyst are dissolved in a solvent, and the solution of 3-diazoindole is slowly added to the mixed solution of the aromatic hydrocarbon and the protonic acid catalyst at 0°C , while vigorously stirring; after the addition of 3-diazoindole dropwise, continue to stir at room temperature for 10 to 60 minutes until the 3-diazoindole is completely consumed; then add excess NaHCO 3 solids to the reaction solution to quench The reaction was quenched, the solid was filtered off and the solvent was removed under reduced pressure; the crude product was subjected to column chromatography (with ethyl acetate:petroleum ether=1:30~1:10 as eluent) to obtain a pure product.
本发明设计的3-芳基氧化吲哚的合成方法,包括以下步骤:The synthetic method of the 3-aryloxindole designed by the present invention comprises the following steps:
按芳烃:3-重氮氧化吲哚:质子酸=5.0:1.0:(0.1~2.0)摩尔比(以3-重氮氧化吲哚用量为基准),称取原料。将所述芳烃和所述质子酸催化剂溶解于溶剂中,制成芳烃和质子酸催化剂的混合溶液;将所述3-重氮氧化吲哚溶解于溶剂中,制成3-重氮氧化吲哚的溶液。在0℃下,将3-重氮氧化吲哚的溶液缓缓加入到所述芳烃和质子酸催化剂的混合溶液中,同时剧烈搅拌;3-重氮氧化吲哚滴加完毕后,室温下继续搅拌10~60分钟,直至3-重氮氧化吲哚消耗完全。然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(以乙酸乙酯:石油醚=1:30~1:10为洗脱剂)得到纯产品。Weigh the raw materials according to the molar ratio of aromatic hydrocarbons: 3-diazoindole: protonic acid = 5.0: 1.0: (0.1-2.0) (based on the amount of 3-diazoindole). The aromatic hydrocarbon and the protonic acid catalyst are dissolved in a solvent to make a mixed solution of the aromatic hydrocarbon and the protonic acid catalyst; the 3-diazoindole is dissolved in a solvent to make a 3-diazoindole The solution. At 0°C, slowly add the solution of 3-diazoindole to the mixed solution of the aromatic hydrocarbon and protonic acid catalyst while vigorously stirring; after the 3-diazoindole is added dropwise, continue to Stir for 10-60 minutes until the 3-diazoindole is completely consumed. Then in the reaction liquid, add excess NaHCO 3 solids to quench the reaction, filter off the solids and remove the solvent under reduced pressure; the crude product is subjected to column chromatography (take ethyl acetate:petroleum ether=1:30~1:10 as eluent) to obtain pure product.
本发明方法中,所述质子酸催化剂是三氟甲磺酸、甲烷磺酸、浓硫酸、氟硼酸、高氯酸、或高碘酸。In the method of the present invention, the protonic acid catalyst is trifluoromethanesulfonic acid, methanesulfonic acid, concentrated sulfuric acid, fluoboric acid, perchloric acid, or periodic acid.
本发明方法中,所述3-重氮氧化吲哚是五元环N原子上无取代或有取代的3-重氮氧化吲哚。In the method of the present invention, the 3-diazoindole is unsubstituted or substituted 3-diazoindole on the N atom of the five-membered ring.
本发明方法中,所述3-重氮氧化吲哚在4、5、6、7位有取代基或没有取代基。In the method of the present invention, the 3-diazoindole has substituents or no substituents at positions 4, 5, 6 and 7.
本发明方法中,所述芳烃为苯、取代苯、萘、菲、蒽、呋喃、噻吩、苯并呋喃、或苯并噻吩。In the method of the present invention, the aromatic hydrocarbon is benzene, substituted benzene, naphthalene, phenanthrene, anthracene, furan, thiophene, benzofuran, or benzothiophene.
本发明方法中,所述溶剂是二氯甲烷、氯仿、1,2-二氯乙烷、四氯化碳、四氢呋喃、乙醚、甲苯、正己烷或环己烷。In the method of the present invention, the solvent is dichloromethane, chloroform, 1,2-dichloroethane, carbon tetrachloride, tetrahydrofuran, ether, toluene, n-hexane or cyclohexane.
本发明具有以下优点和效果:避免使用昂贵的过渡金属催化剂,以廉价易得的芳烃为原料,反应条件温和,反应步骤少,耗时短,成本低,产生的废物少,原子经济性高,操作简单安全可靠。The present invention has the following advantages and effects: avoiding the use of expensive transition metal catalysts, using cheap and easily available aromatic hydrocarbons as raw materials, mild reaction conditions, few reaction steps, short time consumption, low cost, less waste generated, high atom economy, The operation is simple, safe and reliable.
附图说明Description of drawings
图1为实施例1所得产物的1H NMR示意图。FIG. 1 is a schematic diagram of 1 H NMR of the product obtained in Example 1.
图2为实施例1所得产物的13C NMR示意图。FIG. 2 is a schematic diagram of 13 C NMR of the product obtained in Example 1.
图3为实施例2所得产物的1H NMR示意图。FIG. 3 is a schematic diagram of 1 H NMR of the product obtained in Example 2.
图4为实施例2所得产物的13C NMR示意图。FIG. 4 is a schematic diagram of 13 C NMR of the product obtained in Example 2.
图5为实施例3所得产物的1H NMR示意图。FIG. 5 is a schematic diagram of 1 H NMR of the product obtained in Example 3.
图6为实施例3所得产物的13C NMR示意图。FIG. 6 is a schematic diagram of 13 C NMR of the product obtained in Example 3.
图7为实施例4所得产物的1H NMR示意图。FIG. 7 is a schematic diagram of 1 H NMR of the product obtained in Example 4.
图8为实施例4所得产物的13C NMR示意图。FIG. 8 is a schematic diagram of 13 C NMR of the product obtained in Example 4.
图9为实施例5所得产物的1H NMR示意图。FIG. 9 is a schematic diagram of 1 H NMR of the product obtained in Example 5.
图10为实施例5所得产物的13C NMR示意图。FIG. 10 is a schematic diagram of 13 C NMR of the product obtained in Example 5.
图11为实施例6所得产物的1H NMR示意图。FIG. 11 is a schematic diagram of 1 H NMR of the product obtained in Example 6.
图12为实施例6所得产物的13C NMR示意图。FIG. 12 is a schematic diagram of 13 C NMR of the product obtained in Example 6.
图13为实施例7所得产物的1H NMR示意图。FIG. 13 is a schematic diagram of 1 H NMR of the product obtained in Example 7.
图14为实施例7所得产物的13C NMR示意图。FIG. 14 is a schematic diagram of 13 C NMR of the product obtained in Example 7.
图15为实施例8所得产物的1H NMR示意图。Fig. 15 is a schematic diagram of 1 H NMR of the product obtained in Example 8.
图16为实施例8所得产物的13C NMR示意图。FIG. 16 is a schematic diagram of 13 C NMR of the product obtained in Example 8.
图17为实施例9所得产物的1H NMR示意图。FIG. 17 is a schematic diagram of 1 H NMR of the product obtained in Example 9.
图18为实施例9所得产物的13C NMR示意图。FIG. 18 is a schematic diagram of 13 C NMR of the product obtained in Example 9.
图19为实施例10所得产物的1H NMR示意图。FIG. 19 is a schematic diagram of 1 H NMR of the product obtained in Example 10.
图20为实施例10所得产物的13C NMR示意图。20 is a schematic diagram of 13 C NMR of the product obtained in Example 10.
图21为实施例11所得产物的1H NMR示意图。21 is a schematic diagram of 1 H NMR of the product obtained in Example 11.
图22为实施例11所得产物的13C NMR示意图。Fig. 22 is a schematic diagram of 13 C NMR of the product obtained in Example 11.
图23为实施例12所得产物的1H NMR示意图。23 is a schematic diagram of 1 H NMR of the product obtained in Example 12.
图24为实施例12所得产物的13C NMR示意图。24 is a schematic diagram of 13 C NMR of the product obtained in Example 12.
图25为实施例13所得产物的1H NMR示意图。Fig. 25 is a schematic diagram of 1 H NMR of the product obtained in Example 13.
图26为实施例13所得产物的13C NMR示意图。Fig. 26 is a schematic diagram of 13 C NMR of the product obtained in Example 13.
图27为实施例14所得产物的1H NMR示意图。Fig. 27 is a schematic diagram of 1 H NMR of the product obtained in Example 14.
图28为实施例14所得产物的13C NMR示意图。Fig. 28 is a schematic diagram of 13 C NMR of the product obtained in Example 14.
图29为实施例15所得产物的1H NMR示意图。29 is a schematic diagram of 1 H NMR of the product obtained in Example 15.
图30为实施例15所得产物的13C NMR示意图。30 is a schematic diagram of 13 C NMR of the product obtained in Example 15.
图31为实施例16所得产物的1H NMR示意图。Fig. 31 is a schematic diagram of 1 H NMR of the product obtained in Example 16.
图32为实施例16所得产物的13C NMR示意图。Fig. 32 is a schematic diagram of 13 C NMR of the product obtained in Example 16.
具体实施方式Detailed ways
结合以下具体实施例和附图,对本发明作进一步的详细说明。实施本发明的过程、条件、试剂、实验方法等,除以下专门提及的内容之外,均为本领域的普遍知识和公知常识,本发明没有特别限制内容。The present invention will be further described in detail in conjunction with the following specific embodiments and accompanying drawings. The process, conditions, reagents, experimental methods, etc. for implementing the present invention are general knowledge and common knowledge in the art except for the content specifically mentioned below, and the present invention has no special limitation content.
实施例1Example 1
在0℃下,将N-苄基-3-重氮氧化吲哚(1.50g,6.0mmol)的甲苯(12mL)溶液用60分钟的时间缓缓滴入到甲苯(10mL)和三氟甲磺酸(53uL,10mol%)的混合溶液中,同时剧烈搅拌。滴加完毕后,室温下继续搅拌60分钟,直至3-重氮氧化吲哚消耗完全。然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(乙酸乙酯:石油醚=1:30~1:10)得到纯产品N-苄基-3-(对甲苯基)氧化吲哚(1.41g,85%)。1H NMR(CDCl3,400MHz):δ7.31–7.24(m,5H),7.21–7.09(m,6H),7.02–6.98(m,1H),6.77(d,J=7.8Hz 1H),4.99(d,J=15.6Hz 1H),4.88(d,J=15.6Hz 1H),4.66(s,1H),2.33(s,3H).13C NMR(100MHz,CDCl3):δ176.3,143.6,137.3,136.0,133.8,129.7,129.2,128.8,128.3,128.2,127.6,127.4,125.1,122.7,109.2,51.8,44.0,21.1.FTIR(KBr):3050,2922,1711,1612,1487,1464,1383,1347,1177,1083,1030,1008,890,753,733,698cm-1.HRMS(ESI):calcd for C22H19NNaO[M+Na]+=336.1364,found 336.1348.At 0°C, a solution of N-benzyl-3-diazoindole (1.50 g, 6.0 mmol) in toluene (12 mL) was slowly dropped into toluene (10 mL) and trifluoromethanesulfonate over 60 minutes Acid (53uL, 10mol%) mixed solution, while stirring vigorously. After the dropwise addition was completed, stirring was continued at room temperature for 60 minutes until the 3-diazoindole was completely consumed. Then, excess NaHCO3 solid was added to the reaction solution to quench the reaction, the solid was filtered off and the solvent was removed under reduced pressure; the crude product was subjected to column chromatography (ethyl acetate:petroleum ether=1:30~1:10) to obtain Pure product N-benzyl-3-(p-tolyl)oxindole (1.41 g, 85%). 1 H NMR (CDCl 3 , 400MHz): δ7.31–7.24(m,5H),7.21–7.09(m,6H),7.02–6.98(m,1H),6.77(d,J=7.8Hz 1H), 4.99(d, J=15.6Hz 1H), 4.88(d, J=15.6Hz 1H), 4.66(s, 1H), 2.33(s, 3H). 13 C NMR(100MHz, CDCl 3 ): δ176.3, 143.6, 137.3,136.0,133.8,129.7,129.2,128.8,128.3,128.2,127.6,127.4,125.1,122.7,109.2,51.8,44.0,21.1.FTIR(KBr):3050,2922,1711,1612,3487,13 ,1347,1177,1083,1030,1008,890,753,733,698cm -1 .HRMS(ESI):calcd for C 22 H 19 NNaO[M+Na] + =336.1364,found 336.1348.
实施例2Example 2
在0℃下,将N-甲基-3-重氮氧化吲哚(1.07g,6.0mmol)的甲苯(12mL)溶液用60分钟的时间缓缓滴入到甲苯(10mL)和三氟甲磺酸(53uL,10mol%)的混合溶液中,同时剧烈搅拌。滴加完毕后,室温下继续搅拌60分钟,直至3-重氮氧化吲哚消耗完全。然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(乙酸乙酯:石油醚=1:30~1:10)得到纯产品N-甲基-3-(对甲苯基)氧化吲哚(1.04g,73%)。1H NMR(CDCl3,400MHz):δ7.33–7.29(m,1H),7.16–7.03(m,6H),6.88(d,J=8.0Hz 1H),4.56(s,1H),3.24(s,3H),2.31(s,3H).13C NMR(100MHz,CDCl3):δ176.2,144.5,137.3,133.6,129.6,129.1,128.3,128.3,125.0,122.7,108.1,51.7,26.4,21.1.FTIR(KBr):3054,2922,1693,1607,1495,1468,1376,1344,1086,748,693cm-1.HRMS(ESI):calcd for C16H15NNaO[M+Na]+=260.1051,found260.1051.At 0°C, a solution of N-methyl-3-diazoindole (1.07g, 6.0mmol) in toluene (12mL) was slowly dropped into toluene (10mL) and trifluoromethanesulfonate over 60 minutes Acid (53uL, 10mol%) mixed solution, while stirring vigorously. After the dropwise addition was completed, stirring was continued at room temperature for 60 minutes until the 3-diazoindole was completely consumed. Then, excess NaHCO3 solid was added to the reaction solution to quench the reaction, the solid was filtered off and the solvent was removed under reduced pressure; the crude product was subjected to column chromatography (ethyl acetate:petroleum ether=1:30~1:10) to obtain Pure product N-methyl-3-(p-tolyl)oxindole (1.04 g, 73%). 1 H NMR (CDCl 3 , 400MHz): δ7.33–7.29 (m, 1H), 7.16–7.03 (m, 6H), 6.88 (d, J=8.0Hz 1H), 4.56 (s, 1H), 3.24 ( s,3H),2.31(s,3H). 13 C NMR(100MHz,CDCl 3 ):δ176.2,144.5,137.3,133.6,129.6,129.1,128.3,128.3,125.0,122.7,108.1,51.7,26.4,21.1. FTIR(KBr):3054,2922,1693,1607,1495,1468,1376,1344,1086,748,693cm -1 .HRMS(ESI):calcd for C 16 H 15 NNaO[M+Na] + =260.1051,found260 .1051.
实施例3Example 3
在0℃下,将N-乙氧羰基-3-重氮氧化吲哚(6.0mmol)的甲苯(12mL)溶液用60分钟的时间缓缓滴入到甲苯(10mL)和三氟甲磺酸(53uL,10mol%)的混合溶液中,同时剧烈搅拌。滴加完毕后,室温下继续搅拌60分钟,直至3-重氮氧化吲哚消耗完全。然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(乙酸乙酯:石油醚=1:30~1:10)得到纯产品N-乙氧羰基-3-(对甲苯基)氧化吲哚(1.38g,78%)。1H NMR(CDCl3,400MHz):δ7.97(d,J=8.2Hz 1H),7.38–7.34(m,1H),7.21–7.06(m,6H),4.71(s,1H),4.45(q,J=7.1Hz 2H),2.32(s,3H),1.42(t,J=7.1Hz 3H).13C NMR(100MHz,CDCl3):δ174.0,151.1,140.2,137.7,133.2,130.0,128.7,128.4,127.8,125.1,124.9,115.2,63.4,52.2,21.1,14.2.FTIR(KBr):2986,2924,1776,1723,1480,1465,1373,1344,1287,1236,1150,1089,1048,764cm-1.HRMS(ESI):calcd for C18H17NNaO3[M+Na]+=318.1106,found318.1091.At 0°C, a solution of N-ethoxycarbonyl-3-diazoindole (6.0 mmol) in toluene (12 mL) was slowly dropped into toluene (10 mL) and trifluoromethanesulfonic acid ( 53uL, 10mol%) in the mixed solution while vigorously stirring. After the dropwise addition was completed, stirring was continued at room temperature for 60 minutes until the 3-diazoindole was completely consumed. Then, excess NaHCO3 solid was added to the reaction solution to quench the reaction, the solid was filtered off and the solvent was removed under reduced pressure; the crude product was subjected to column chromatography (ethyl acetate:petroleum ether=1:30~1:10) to obtain Pure product N-ethoxycarbonyl-3-(p-tolyl)oxindole (1.38 g, 78%). 1 H NMR (CDCl 3 , 400MHz): δ7.97 (d, J=8.2Hz 1H), 7.38–7.34 (m, 1H), 7.21–7.06 (m, 6H), 4.71 (s, 1H), 4.45 ( q, J=7.1Hz 2H), 2.32(s, 3H), 1.42(t, J=7.1Hz 3H). 13 C NMR (100MHz, CDCl 3 ): δ174.0, 151.1, 140.2, 137.7, 133.2, 130.0, 128.7 ,128.4,127.8,125.1,124.9,115.2,63.4,52.2,21.1,14.2.FTIR(KBr):2986,2924,1776,1723,1480,1465,1373,1344,1287,1236,1150,1089,1048, 764cm -1 .HRMS(ESI): calcd for C 18 H 17 NNaO 3 [M+Na] + =318.1106, found 318.1091.
实施例4Example 4
在0℃下,将4-氯-N-苄基-3-重氮氧化吲哚(6.0mmol)的甲苯(12mL)溶液用60分钟的时间缓缓滴入到甲苯(10mL)和三氟甲磺酸(53uL,10mol%)的混合溶液中,同时剧烈搅拌。滴加完毕后,室温下继续搅拌60分钟,直至3-重氮氧化吲哚消耗完全。然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(乙酸乙酯:石油醚=1:30~1:10)得到纯产品4-氯-N-苄基-3-(对甲苯基)氧化吲哚(1.54g,74%)。1H NMR(400MHz,CDCl3):δ7.31–7.24(m,5H),7.17–7.13(m,3H),7.06(d,J=7.9Hz,2H),6.97(d,J=8.2Hz,1H),6.68(d,J=7.8Hz,1H),4.97(d,J=15.6Hz,1H),4.82(d,J=15.6Hz,1H),4.68(s,1H),2.33(s,3H).13C NMR(100MHz,CDCl3):δ175.5,145.3,137.4,135.6,131.8,131.6,129.7,129.7,128.9,128.0,127.8,127.3,126.6,123.3,107.5,51.7,44.2,21.2.FTIR(KBr):3408,3024,2919,1711,1606,1460,1334,1232,1161,1142,1025,802,774,724,699,503cm-1.HRMS(ESI):calcd for C22H18ClNNaO[M+Na]+=370.0975,found370.0974.At 0°C, a solution of 4-chloro-N-benzyl-3-diazoindole (6.0 mmol) in toluene (12 mL) was slowly dropped into toluene (10 mL) and trifluoromethane over 60 minutes Sulfonic acid (53uL, 10mol%) mixed solution, while vigorously stirring. After the dropwise addition was completed, stirring was continued at room temperature for 60 minutes until the 3-diazoindole was completely consumed. Then, excess NaHCO3 solid was added to the reaction solution to quench the reaction, the solid was filtered off and the solvent was removed under reduced pressure; the crude product was subjected to column chromatography (ethyl acetate:petroleum ether=1:30~1:10) to obtain Pure product 4-chloro-N-benzyl-3-(p-tolyl)oxindole (1.54 g, 74%). 1 H NMR (400MHz, CDCl 3 ): δ7.31–7.24(m,5H),7.17–7.13(m,3H),7.06(d,J=7.9Hz,2H),6.97(d,J=8.2Hz ,1H),6.68(d,J=7.8Hz,1H),4.97(d,J=15.6Hz,1H),4.82(d,J=15.6Hz,1H),4.68(s,1H),2.33(s ,3H). 13 C NMR (100MHz, CDCl 3 ): δ175.5, 145.3, 137.4, 135.6, 131.8, 131.6, 129.7, 129.7, 128.9, 128.0, 127.8, 127.3, 126.6, 123.3, 107.5, 51.7, 44.2, 2 FTIR(KBr):3408,3024,2919,1711,1606,1460,1334,1232,1161,1142,1025,802,774,724,699,503cm -1 .HRMS(ESI):calcd for C 22 H 18 ClNNaO[M+Na] + =370.0975, found 370.0974.
实施例5Example 5
在0℃下,将5-氯-N-苄基-3-重氮氧化吲哚(6.0mmol)的甲苯(12mL)溶液用60分钟的时间缓缓滴入到甲苯(10mL)和三氟甲磺酸(53uL,10mol%)的混合溶液中,同时剧烈搅拌。滴加完毕后,室温下继续搅拌60分钟,直至3-重氮氧化吲哚消耗完全。然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(乙酸乙酯:石油醚=1:30~1:10)得到纯产品5-氯-N-苄基-3-(对甲苯基)氧化吲哚(1.42g,68%)。1H NMR(400MHz,CDCl3):δ7.31–7.23(m,5H),7.17–7.12(m,4H),7.08(d,J=8.0Hz2H),6.67(d,J=8.3Hz 1H),4.97(d,J=15.6Hz 1H),4.86(d,J=15.6Hz 1H),4.64(s,1H),2.33(s,3H).13C NMR(100MHz,CDCl3):δ175.8,142.1,137.7,135.5,133.0,130.9,129.8,128.9,128.3,128.2,128.2,127.8,127.3,125.5,110.1,51.8,44.1,21.1.FTIR(KBr):3031,2922,1722,1711,1607,1484,1427,1340,1160,1113,804,744,700cm-1.HRMS(ESI):calcd for C22H18ClNNaO[M+Na]+=370.0975,found 370.0962.At 0°C, a solution of 5-chloro-N-benzyl-3-diazoindole (6.0 mmol) in toluene (12 mL) was slowly dropped into toluene (10 mL) and trifluoromethane over 60 minutes Sulfonic acid (53uL, 10mol%) mixed solution, while vigorously stirring. After the dropwise addition was completed, stirring was continued at room temperature for 60 minutes until the 3-diazoindole was completely consumed. Then, excess NaHCO3 solid was added to the reaction solution to quench the reaction, the solid was filtered off and the solvent was removed under reduced pressure; the crude product was subjected to column chromatography (ethyl acetate:petroleum ether=1:30~1:10) to obtain Pure product 5-chloro-N-benzyl-3-(p-tolyl)oxindole (1.42 g, 68%). 1 H NMR (400MHz, CDCl 3 ): δ7.31–7.23(m,5H),7.17–7.12(m,4H),7.08(d,J=8.0Hz2H),6.67(d,J=8.3Hz 1H) ,4.97(d,J=15.6Hz 1H),4.86(d,J=15.6Hz 1H),4.64(s,1H),2.33(s,3H). 13 C NMR(100MHz,CDCl 3 ):δ175.8,142.1 ,137.7,135.5,133.0,130.9,129.8,128.9,128.3,128.2,128.2,127.8,127.3,125.5,110.1,51.8,44.1,21.1.FTIR(KBr):3031,2922,1722,1711,1607, 1427,1340,1160,1113,804,744,700cm -1 .HRMS(ESI):calcd for C 22 H 18 ClNNaO[M+Na] + =370.0975,found 370.0962.
实施例6Example 6
在0℃下,将6-氯-N-苄基-3-重氮氧化吲哚(6.0mmol)的甲苯(12mL)溶液用60分钟的时间缓缓滴入到甲苯(10mL)和三氟甲磺酸(53uL,10mol%)的混合溶液中,同时剧烈搅拌。滴加完毕后,室温下继续搅拌60分钟,直至3-重氮氧化吲哚消耗完全。然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(乙酸乙酯:石油醚=1:30~1:10)得到纯产品6-氯-N-苄基-3-(对甲苯基)氧化吲哚(1.25g,60%)。1H NMR(400MHz,CDCl3):δ7.33–7.24(m,5H),7.15(d,J=7.9Hz 2H),7.08–7.04(m,3H),6.98(d,J=7.9,1.5Hz 1H),6.77(d,J=1.3Hz 1H),4.95(d,J=15.6Hz 1H),4.84(d,J=15.6Hz 1H),4.62(s,1H),2.33(s,3H).13C NMR(100MHz,CDCl3):δ176.2,144.8,137.6,135.4,134.0,133.2,129.8,128.9,128.2,127.9,127.5,127.3,126.0,122.7,109.7,51.3,44.1,21.1.FTIR(KBr):3411,3030,2923,1711,1609,1490,1336,1183,1080,798,698cm- 1.HRMS(ESI):calcd for C22H18ClNNaO[M+Na]+=370.0975,found 370.0972.At 0°C, a solution of 6-chloro-N-benzyl-3-diazoindole (6.0 mmol) in toluene (12 mL) was slowly dropped into toluene (10 mL) and trifluoromethane over 60 minutes Sulfonic acid (53uL, 10mol%) mixed solution, while vigorously stirring. After the dropwise addition was completed, stirring was continued at room temperature for 60 minutes until the 3-diazoindole was completely consumed. Then, excess NaHCO3 solid was added to the reaction solution to quench the reaction, the solid was filtered off and the solvent was removed under reduced pressure; the crude product was subjected to column chromatography (ethyl acetate:petroleum ether=1:30~1:10) to obtain Pure product 6-chloro-N-benzyl-3-(p-tolyl)oxindole (1.25 g, 60%). 1 H NMR (400MHz, CDCl 3 ): δ7.33–7.24(m,5H),7.15(d,J=7.9Hz 2H),7.08–7.04(m,3H),6.98(d,J=7.9,1.5 Hz 1H), 6.77(d, J=1.3Hz 1H), 4.95(d, J=15.6Hz 1H), 4.84(d, J=15.6Hz 1H), 4.62(s, 1H), 2.33(s, 3H) . 13 C NMR (100MHz, CDCl 3 ): δ176.2, 144.8, 137.6, 135.4, 134.0, 133.2, 129.8, 128.9, 128.2, 127.9, 127.5, 127.3, 126.0, 122.7, 109.7, 51.3, 44.1IR (21K.1 ):3411,3030,2923,1711,1609,1490,1336,1183,1080,798,698cm - 1 .HRMS(ESI):calcd for C 22 H 18 ClNNaO[M+Na] + =370.0975,found 370.0972.
实施例7Example 7
在0℃下,将5-溴-N-苄基-3-重氮氧化吲哚(6.0mmol)的甲苯(122mL)溶液用60分钟的时间缓缓滴入到甲苯(10mL)和三氟甲磺酸(53uL,10mol%)的混合溶液中,同时剧烈搅拌。滴加完毕后,室温下继续搅拌60分钟,直至3-重氮氧化吲哚消耗完全。然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(乙酸乙酯:石油醚=1:30~1:10)得到纯产品5-溴-N-苄基-3-(对甲苯基)氧化吲哚(2.0g,85%)。1H NMR(400MHz,CDCl3):δ7.31–7.24(m,7H),7.16(d,J=8.0Hz 2H),7.07(d,J=8.0Hz 2H),6.63(d,J=8.3Hz 1H),4.97(d,J=15.6Hz 1H),4.86(d,J=15.6Hz 1H),4.65(s,1H),2.34(s,3H).13C NMR(100MHz,CDCl3):δ175.7,142.6,137.7,135.5,133.0,131.3,131.1,129.8,128.9,128.3,128.2,127.8,127.3,115.5,110.6,51.7,44.0,21.1.FTIR(KBr):3428,2922,1722,1712,1604,1484,1423,1347,1184,1159,1112,1023,803,739,698cm-1.HRMS(ESI):calcd for C22H18BrNNaO[M+Na]+=414.0469,found414.0465.At 0°C, a solution of 5-bromo-N-benzyl-3-diazoindole (6.0 mmol) in toluene (122 mL) was slowly dropped into toluene (10 mL) and trifluoromethane over 60 minutes Sulfonic acid (53uL, 10mol%) mixed solution, while vigorously stirring. After the dropwise addition was completed, stirring was continued at room temperature for 60 minutes until the 3-diazoindole was completely consumed. Then, excess NaHCO3 solid was added to the reaction solution to quench the reaction, the solid was filtered off and the solvent was removed under reduced pressure; the crude product was subjected to column chromatography (ethyl acetate:petroleum ether=1:30~1:10) to obtain Pure product 5-bromo-N-benzyl-3-(p-tolyl)oxindole (2.0 g, 85%). 1 H NMR (400MHz, CDCl 3 ): δ7.31–7.24(m, 7H), 7.16(d, J=8.0Hz 2H), 7.07(d, J=8.0Hz 2H), 6.63(d, J=8.3 Hz 1H), 4.97(d, J=15.6Hz 1H), 4.86(d, J=15.6Hz 1H), 4.65(s, 1H), 2.34(s, 3H). 13 C NMR (100MHz, CDCl 3 ): δ175.7, 142.6, 137.7, 135.5, 133.0, 131.3, 131.1, 129.8, 128.9, 128.3, 128.2, 127.8, 127.3, 115.5, 110.6, 51.7, 44.0, 21.1. ,1484,1423,1347,1184,1159,1112,1023,803,739,698cm -1 .HRMS(ESI):calcd for C 22 H 18 BrNNaO[M+Na] + =414.0469,found414.0465.
实施例8Example 8
在0℃下,将5-甲基-N-苄基-3-重氮氧化吲哚(6.0mmol)的甲苯(12mL)溶液用60分钟的时间缓缓滴入到甲苯(10mL)和三氟甲磺酸(53uL,10mol%)的混合溶液中,同时剧烈搅拌。滴加完毕后,室温下继续搅拌60分钟,直至3-重氮氧化吲哚消耗完全。然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(乙酸乙酯:石油醚=1:30~1:10)得到纯产品5-甲基-N-苄基-3-(对甲苯基)氧化吲哚(1.45g,74%)。1H NMR(400MHz,CDCl3):δ7.30–7.22(m,5H),7.15(d,J=8.0Hz 2H),7.10(d,J=8.0Hz 2H),6.97(d,J=8.7Hz 2H),6.65(d,J=7.7Hz 1H),4.97(d,J=15.6Hz 1H),4.86(d,J=15.6Hz 1H),4.62(s,1H),2.33(s,3H),2.24(s,3H).13C NMR(100MHz,CDCl3):δ176.3,141.2,137.3,136.1,134.0,132.3,129.7,129.3,128.8,128.5,128.4,127.6,127.4,125.9,108.9,51.9,44.0,21.2,21.0.FTIR(KBr):3028,2918,1709,1600,1494,1346,1186,1022,890,818,758,732,694,653cm-1.HRMS(ESI):calcd for C23H21NNaO[M+Na]+=350.1521,found350.1536.At 0°C, a solution of 5-methyl-N-benzyl-3-diazoindole (6.0 mmol) in toluene (12 mL) was slowly dropped into toluene (10 mL) and trifluoro methanesulfonic acid (53uL, 10mol%) in the mixed solution while vigorously stirring. After the dropwise addition was completed, stirring was continued at room temperature for 60 minutes until the 3-diazoindole was completely consumed. Then, excess NaHCO3 solid was added to the reaction solution to quench the reaction, the solid was filtered off and the solvent was removed under reduced pressure; the crude product was subjected to column chromatography (ethyl acetate:petroleum ether=1:30~1:10) to obtain Pure product 5-methyl-N-benzyl-3-(p-tolyl)oxindole (1.45 g, 74%). 1 H NMR (400MHz, CDCl 3 ): δ7.30–7.22(m, 5H), 7.15(d, J=8.0Hz 2H), 7.10(d, J=8.0Hz 2H), 6.97(d, J=8.7 Hz 2H), 6.65(d, J=7.7Hz 1H), 4.97(d, J=15.6Hz 1H), 4.86(d, J=15.6Hz 1H), 4.62(s, 1H), 2.33(s, 3H) ,2.24(s,3H). 13 C NMR(100MHz,CDCl 3 ):δ176.3,141.2,137.3,136.1,134.0,132.3,129.7,129.3,128.8,128.5,128.4,127.6,127.4,125.9,108.9,51.9 44.0,21.2,21.0.FTIR(KBr):3028,2918,1709,1600,1494,1346,1186,1022,890,818,758,732,694,653cm -1 .HRMS(ESI):calcd for C 23 H 21 NNaO[M+Na] + =350.1521, found 350.1536.
实施例9Example 9
在0℃下,将6-氟-N-苄基-3-重氮氧化吲哚(6.0mmol)的甲苯(12mL)溶液用60分钟的时间缓缓滴入到甲苯(10mL)和三氟甲磺酸(53uL,10mol%)的混合溶液中,同时剧烈搅拌。滴加完毕后,室温下继续搅拌60分钟,直至3-重氮氧化吲哚消耗完全。然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(乙酸乙酯:石油醚=1:30~1:10)得到纯产品6-氟-N-苄基-3-(对甲苯基)氧化吲哚(1.39g,70%)。1H NMR(400MHz,CDCl3):δ7.34–7.24(m,5H),7.15(d,J=7.9Hz2H),7.09–7.05(m,3H),6.72–6.64(m,1H),6.51(dd,J1=8.9Hz,J2=2.2Hz 1H),4.95(d,J=15.6Hz 1H),4.84(d,J=15.6Hz 1H),4.62(s,1H),2.33(s,3H).13C NMR(100MHz,CDCl3):δ176.6,163.0(d,JC-F=245.0Hz)145.0(d,JC-F=11.5Hz),137.5,135.5,133.5,129.7,128.9,128.2,127.9,127.4,126.0(d,JC-F=9.6Hz),124.4(d,JC-F=3.0Hz),108.9(d,JC-F=22.4Hz),98.0(d,JC-F=27.7Hz),51.2,44.1,21.1.FTIR(KBr):3400,3067,2923,1710,1605,1497,1453,1374,1342,1167,1079,939,697cm-1.HRMS(ESI):calcd for C22H18FNNaO[M+Na]+=354.1270,found354.1259.At 0°C, a solution of 6-fluoro-N-benzyl-3-diazoindole (6.0 mmol) in toluene (12 mL) was slowly dropped into toluene (10 mL) and trifluoromethane over 60 minutes Sulfonic acid (53uL, 10mol%) mixed solution, while vigorously stirring. After the dropwise addition was completed, stirring was continued at room temperature for 60 minutes until the 3-diazoindole was completely consumed. Then, excess NaHCO3 solid was added to the reaction solution to quench the reaction, the solid was filtered off and the solvent was removed under reduced pressure; the crude product was subjected to column chromatography (ethyl acetate:petroleum ether=1:30~1:10) to obtain Pure product 6-fluoro-N-benzyl-3-(p-tolyl)oxindole (1.39 g, 70%). 1 H NMR (400MHz, CDCl 3 ): δ7.34–7.24(m,5H),7.15(d,J=7.9Hz2H),7.09–7.05(m,3H),6.72–6.64(m,1H),6.51 (dd,J 1 =8.9Hz,J 2 =2.2Hz 1H),4.95(d,J=15.6Hz 1H),4.84(d,J=15.6Hz 1H),4.62(s,1H),2.33(s, 3H). 13 C NMR (100MHz, CDCl 3 ): δ176.6, 163.0 (d, J CF = 245.0 Hz), 145.0 (d, J CF = 11.5 Hz), 137.5, 135.5, 133.5, 129.7, 128.9, 128.2, 127.9, 127.4, 126.0(d, J CF =9.6Hz), 124.4(d, J CF =3.0Hz), 108.9(d, J CF =22.4Hz), 98.0(d, J CF =27.7Hz), 51.2, 44.1, 21.1.FTIR(KBr):3400,3067,2923,1710,1605,1497,1453,1374,1342,1167,1079,939,697cm -1 .HRMS(ESI):calcd for C 22 H 18 FNNaO[M+Na ] + =354.1270,found354.1259.
实施例10Example 10
在0℃下,将N-苄基-3-重氮氧化吲哚(1.50g,6.0mmol)的1,2-二氯乙烷(12mL)溶液用60分钟的时间缓缓滴入到异丁基苯(30mmol)和三氟甲磺酸(106uL,20mol%)的1,2-二氯乙烷(10mL)溶液中,同时剧烈搅拌。滴加完毕后,室温下继续搅拌60分钟,直至3-重氮氧化吲哚消耗完全。然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(乙酸乙酯:石油醚=1:30~1:10)得到纯产品N-苄基-3-(异丁基苯基)氧化吲哚(1.07g,50%)。1H NMR(CDCl3,400MHz):δ7.32–7.12(m,11H),7.02–6.98(m,1H),6.77(d,J=7.8Hz 1H),4.98(d,J=15.6Hz 1H),4.90(d,J=15.6Hz 1H),4.67(s,1H),2.45(d,J=7.1Hz 2H),1.90–1.80(m,1H),0.90(d,J=6.6Hz 6H).13C NMR(100MHz,CDCl3):δ176.4,143.6,141.1,136.0,133.9,129.7,129.2,128.8,128.2,128.1,127.6,127.4,125.1,122.7,109.2,51.8,45.1,44.0,30.2,22.4,22.4.FTIR(KBr):3411,3056,2948,2922,1711,1609,1488,1466,1357,1199,1165,748,731,699cm-1.HRMS(ESI):calcdfor C25H25NNaO[M+Na]+=378.1270,found378.1287.At 0°C, a solution of N-benzyl-3-diazoindole (1.50g, 6.0mmol) in 1,2-dichloroethane (12mL) was slowly dropped into isobutylene over 60 minutes Benzene (30mmol) and trifluoromethanesulfonic acid (106uL, 20mol%) in 1,2-dichloroethane (10mL) while vigorously stirring. After the dropwise addition was completed, stirring was continued at room temperature for 60 minutes until the 3-diazoindole was completely consumed. Then, excess NaHCO3 solid was added to the reaction solution to quench the reaction, the solid was filtered off and the solvent was removed under reduced pressure; the crude product was subjected to column chromatography (ethyl acetate:petroleum ether=1:30~1:10) to obtain Pure product N-benzyl-3-(isobutylphenyl)oxindole (1.07 g, 50%). 1 H NMR (CDCl 3 , 400MHz): δ7.32–7.12(m,11H),7.02–6.98(m,1H),6.77(d,J=7.8Hz 1H),4.98(d,J=15.6Hz 1H ),4.90(d,J=15.6Hz 1H),4.67(s,1H),2.45(d,J=7.1Hz 2H),1.90–1.80(m,1H),0.90(d,J=6.6Hz 6H) . 13 C NMR (100MHz, CDCl 3 ): δ176.4, 143.6, 141.1, 136.0, 133.9, 129.7, 129.2, 128.8, 128.2, 128.1, 127.6, 127.4, 125.1, 122.7, 109.2, 51.8, 45.1, 44.0, 2 ,22.4.FTIR(KBr):3411,3056,2948,2922,1711,1609,1488,1466,1357,1199,1165,748,731,699cm -1 .HRMS(ESI):calcdfor C 25 H 25 NNaO[M+Na ] + =378.1270,found378.1287.
实施例11Example 11
在0℃下,将N-苄基-3-重氮氧化吲哚(1.50g,6.0mmol)的1,2-二氯乙烷(12mL)溶液用60分钟的时间缓缓滴入到联苯(30mmol)和三氟甲磺酸(106uL,20mol%)的1,2-二氯乙烷(10mL)溶液中,同时剧烈搅拌。滴加完毕后,室温下继续搅拌60分钟,直至3-重氮氧化吲哚消耗完全。然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(乙酸乙酯:石油醚=1:30~1:10)得到纯产品N-苄基-3-(联苯基)氧化吲哚(1.28g,57%)。1H NMR(CDCl3,400MHz):δ7.56(d,J=8.1Hz4H),7.44–7.40(m,2H),7.35–7.23(m,8H),7.23–7.19(m,2H),7.05–7.01(m,1H),6.80(d,J=7.7Hz 1H),5.00(d,J=15.6Hz 1H),4.91(d,J=15.6Hz 1H),4.74(s,1H).13C NMR(100MHz,CDCl3):δ176.1,143.7,140.8,140.7,135.9,135.8,128.9,128.8,128.8,128.4,127.8,127.7,127.4,127.6,127.1,125.20,122.6,109.3,51.8,44.0.FTIR(KBr):3411,3031,2923,1711,1608,1487,1466,1354,1197,1007,762,750,695cm-1.HRMS(ESI):calcd for C27H21NNaO[M+Na]+=398.1521,found398.1520.At 0°C, a solution of N-benzyl-3-diazoindole (1.50 g, 6.0 mmol) in 1,2-dichloroethane (12 mL) was slowly dropped into biphenyl over 60 minutes (30mmol) and trifluoromethanesulfonic acid (106uL, 20mol%) in 1,2-dichloroethane (10mL) solution while vigorously stirring. After the dropwise addition was completed, stirring was continued at room temperature for 60 minutes until the 3-diazoindole was completely consumed. Then, excess NaHCO3 solid was added to the reaction solution to quench the reaction, the solid was filtered off and the solvent was removed under reduced pressure; the crude product was subjected to column chromatography (ethyl acetate:petroleum ether=1:30~1:10) to obtain Pure product N-benzyl-3-(biphenyl)oxindole (1.28 g, 57%). 1 H NMR (CDCl 3 , 400MHz): δ7.56 (d, J=8.1Hz4H), 7.44–7.40 (m, 2H), 7.35–7.23 (m, 8H), 7.23–7.19 (m, 2H), 7.05 –7.01(m, 1H), 6.80(d, J=7.7Hz 1H), 5.00(d, J=15.6Hz 1H), 4.91(d, J=15.6Hz 1H), 4.74(s, 1H). 13 C NMR (100MHz, CDCl 3 ): δ176.1, 143.7, 140.8, 140.7, 135.9, 135.8, 128.9, 128.8, 128.8, 128.4, 127.8, 127.7, 127.4, 127.6, 127.1, 125.20, 122.6, 109.3, 4.5 (IR KBr):3411,3031,2923,1711,1608,1487,1466,1354,1197,1007,762,750,695cm -1 .HRMS(ESI):calcd for C 27 H 21 NNaO[M+Na] + =398.1521,found398 .1520.
实施例12Example 12
在0℃下,将N-苄基-3-重氮氧化吲哚(1.50g,6.0mmol)的1,2-二氯乙烷(12mL)溶液用60分钟的时间缓缓滴入到对甲氧基苯(30mmol)和三氟甲磺酸(106uL,20mol%)的1,2-二氯乙烷(10mL)溶液中,同时剧烈搅拌。滴加完毕后,室温下继续搅拌60分钟,直至3-重氮氧化吲哚消耗完全。然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(乙酸乙酯:石油醚=1:30~1:10)得到纯产品N-苄基-3-(对甲氧基苯基)氧化吲哚(1.60g,81%)。1H NMR(CDCl3,400MHz):δ7.32–7.13(m,9H),7.02–6.99(m,1H),6.88(d,J=8.6Hz 2H),6.77(d,J=7.7Hz 1H),4.98(d,J=15.6Hz 1H),4.88(d,J=15.6Hz 1H),4.64(s,1H),3.78(s,3H).13C NMR(100MHz,CDCl3):δ176.5,159.1,143.6,136.0,129.5,129.2,128.8,128.7,128.3,127.6,127.4,125.1,122.8,114.4,109.2,55.3,51.3,43.9.FTIR(KBr):3025,2923,1710,1609,1515,1486,1467,1346,1255,1180,1023,752,696cm-1.HRMS(ESI):calcd for C22H19NNaO2[M+Na]+=352.1313,found352.1300.At 0°C, a solution of N-benzyl-3-diazoindole (1.50 g, 6.0 mmol) in 1,2-dichloroethane (12 mL) was slowly dropped into p-methanol over 60 minutes Oxybenzene (30mmol) and trifluoromethanesulfonic acid (106uL, 20mol%) in 1,2-dichloroethane (10mL) solution while vigorously stirring. After the dropwise addition was completed, stirring was continued at room temperature for 60 minutes until the 3-diazoindole was completely consumed. Then, excess NaHCO3 solid was added to the reaction solution to quench the reaction, the solid was filtered off and the solvent was removed under reduced pressure; the crude product was subjected to column chromatography (ethyl acetate:petroleum ether=1:30~1:10) to obtain Pure product N-benzyl-3-(p-methoxyphenyl)oxindole (1.60 g, 81%). 1 H NMR (CDCl 3 , 400MHz): δ7.32–7.13(m,9H),7.02–6.99(m,1H),6.88(d,J=8.6Hz 2H),6.77(d,J=7.7Hz 1H ), 4.98(d, J=15.6Hz 1H), 4.88(d, J=15.6Hz 1H), 4.64(s, 1H), 3.78(s, 3H). 13 C NMR(100MHz, CDCl 3 ): δ176. 5,159.1,143.6,136.0,129.5,129.2,128.8,128.7,128.3,127.6,127.4,125.1,122.8,114.4,109.2,55.3,51.3,43.9.FTIR(KBr):3025,2923,191,410,165 ,1467,1346,1255,1180,1023,752,696cm -1 .HRMS(ESI):calcd for C 22 H 19 NNaO 2 [M+Na] + =352.1313,found352.1300.
实施例13Example 13
在0℃下,将N-苄基-3-重氮氧化吲哚(1.50g,6.0mmol)的1,2-二氯乙烷(12mL)溶液用60分钟的时间缓缓滴入到乙酰苯胺(30mmol)和三氟甲磺酸(1.06mL,200mol%)的1,2-二氯乙烷(10mL)溶液中,同时剧烈搅拌。滴加完毕后,室温下继续搅拌60分钟,直至3-重氮氧化吲哚消耗完全。然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(乙酸乙酯:石油醚=1:30~1:10)得到纯产品N-苄基-3-(对乙酰氨基苯基)氧化吲哚(1.29g,60%)。1H NMR(CDCl3,400MHz):δ7.96(s,1H),7.38(d,J=8.3Hz 2H),7.30–7.19(m,6H),7.13(d,J=7.3Hz 1H),7.08(d,J=8.3Hz 2H),7.04–7.00(m,1H),6.80(d,J=7.8Hz 1H),4.99(d,J=15.6Hz 1H),4.90(d,J=15.6Hz 1H),4.65(s,1H),2.10(s,3H).13C NMR(101MHz,CDCl3):δ176.5,168.6,143.4,137.7,135.8,132.0,128.9,128.9,128.4,127.7,127.3,125.2,123.0,120.6,109.3,51.7,44.0,24.4.FTIR(KBr):3314,2923,2852,1710,1692,1609,1513,1487,1465,1410,1363,1316,1268,1182,1010,751,697cm-1.HRMS(ESI):calcd for C23H21N2O2[M+H]+=357.1603,found 357.1615.At 0°C, a solution of N-benzyl-3-diazoindole (1.50 g, 6.0 mmol) in 1,2-dichloroethane (12 mL) was slowly dropped into acetanilide over 60 minutes (30mmol) and trifluoromethanesulfonic acid (1.06mL, 200mol%) in 1,2-dichloroethane (10mL) solution while vigorously stirring. After the dropwise addition was completed, stirring was continued at room temperature for 60 minutes until the 3-diazoindole was completely consumed. Then, excess NaHCO3 solid was added to the reaction solution to quench the reaction, the solid was filtered off and the solvent was removed under reduced pressure; the crude product was subjected to column chromatography (ethyl acetate:petroleum ether=1:30~1:10) to obtain Pure product N-benzyl-3-(p-acetamidophenyl)oxindole (1.29 g, 60%). 1 H NMR (CDCl 3 , 400MHz): δ7.96(s, 1H), 7.38(d, J=8.3Hz 2H), 7.30–7.19(m, 6H), 7.13(d, J=7.3Hz 1H), 7.08(d,J=8.3Hz 2H),7.04–7.00(m,1H),6.80(d,J=7.8Hz 1H),4.99(d,J=15.6Hz 1H),4.90(d,J=15.6Hz 1H), 4.65(s, 1H), 2.10(s, 3H). 13 C NMR (101MHz, CDCl 3 ): δ176.5, 168.6, 143.4, 137.7, 135.8, 132.0, 128.9, 128.9, 128.4, 127.7, 127.3, 125.2 . -1 .HRMS(ESI): calcd for C 23 H 21 N 2 O 2 [M+H] + =357.1603, found 357.1615.
实施例14Example 14
在0℃下,将N-苄基-3-重氮氧化吲哚(1.50g,6.0mmol)的1,2-二氯乙烷(12mL)溶液用60分钟的时间缓缓滴入到邻二甲苯(30mmol)和三氟甲磺酸(106uL,20mol%)的1,2-二氯乙烷(10mL)溶液中,同时剧烈搅拌。滴加完毕后,室温下继续搅拌60分钟,直至3-重氮氧化吲哚消耗完全。然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(乙酸乙酯:石油醚=1:30~1:10)得到纯产品N-苄基-3-(3,4-二甲基苯基)氧化吲哚(1.41g,72%)。1H NMR(CDCl3,400MHz):δ7.33–7.13(m,7H),7.09(d,J=7.7Hz 1H),7.01–6.98(m,2H),6.92(d,J=7.7Hz 1H),6.77(d,J=7.8Hz 1H),4.98(d,J=15.6Hz 1H),4.88(d,J=15.6Hz 1H),4.62(s,1H),2.23(s,3H),2.22(s,3H).13CNMR(100MHz,CDCl3):δ176.5,143.6,137.2,136.1,136.0,134.2,130.2,129.7,129.7,128.8,128.2,127.7,127.4,125.8,125.1,122.8,109.1,51.8,44.0,19.9,19.5.FTIR(KBr):3032,2921,1711,1611,1486,1466,1346,1181,1081,751,697cm-1.HRMS(ESI):calcdfor C23H21NNaO[M+Na]+=350.1521,found350.1511.At 0°C, a solution of N-benzyl-3-diazoindole (1.50g, 6.0mmol) in 1,2-dichloroethane (12mL) was slowly dropped into o-dichloroethane over 60 minutes Toluene (30mmol) and trifluoromethanesulfonic acid (106uL, 20mol%) in 1,2-dichloroethane (10mL) solution, while vigorously stirring. After the dropwise addition was completed, stirring was continued at room temperature for 60 minutes until the 3-diazoindole was completely consumed. Then, excess NaHCO3 solid was added to the reaction solution to quench the reaction, the solid was filtered off and the solvent was removed under reduced pressure; the crude product was subjected to column chromatography (ethyl acetate:petroleum ether=1:30~1:10) to obtain Pure product N-benzyl-3-(3,4-dimethylphenyl)oxindole (1.41 g, 72%). 1 H NMR (CDCl 3 , 400MHz): δ7.33–7.13(m,7H),7.09(d,J=7.7Hz 1H),7.01–6.98(m,2H),6.92(d,J=7.7Hz 1H ),6.77(d,J=7.8Hz 1H),4.98(d,J=15.6Hz 1H),4.88(d,J=15.6Hz 1H),4.62(s,1H),2.23(s,3H),2.22 (s,3H). 13 CNMR (100MHz, CDCl 3 ): δ176.5, 143.6, 137.2, 136.1, 136.0, 134.2, 130.2, 129.7, 129.7, 128.8, 128.2, 127.7, 127.4, 125.8, 125.1, 121.8, 108.9 ,44.0,19.9,19.5.FTIR(KBr):3032,2921,1711,1611,1486,1466,1346,1181,1081,751,697cm -1 .HRMS(ESI):calcdfor C 23 H 21 NNaO[M+Na ] + =350.1521,found350.1511.
实施例15Example 15
在0℃下,将N-苄基-3-重氮氧化吲哚(1.50g,6.0mmol)的1,2-二氯乙烷(12mL)溶液用60分钟的时间缓缓滴入到间苯二甲醚(30mmol)和三氟甲磺酸(106uL,20mol%)的1,2-二氯乙烷(10mL)溶液中,同时剧烈搅拌。滴加完毕后,室温下继续搅拌60分钟,直至3-重氮氧化吲哚消耗完全。然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(乙酸乙酯:石油醚=1:30~1:10)得到纯产品N-苄基-3-(2,4-二甲氧基苯基)氧化吲哚(1.94g,90%)。1H NMR(CDCl3,400MHz):δ7.39–7.24(m,5H),7.15–7.11(m,1H),7.04–7.02(m,2H),6.04–6.90(m,1H),6.74(d,J=7.8Hz 1H),6.47–6.45(m,2H),5.10(d,J=15.6Hz 1H),4.85(d,J=15.6Hz 1H),4.82(s,1H),3.78(s,3H),3.59(s,3H).13C NMR(100MHz,CDCl3):δ177.0,160.6,158.5,143.3,136.3,130.9,130.1,128.7,127.6,127.6,127.5,124.0,122.4,118.2,108.7,104.7,99.5,55.6,55.4,48.0,43.9.FTIR(KBr):3410,3024,2923,1711,1611,1487,1466,1347,1209,1160,1129,1082,1047,1025,750,699cm-1.HRMS(ESI):calcd for C23H21NNaO3[M+Na]+=382.1419,found382.1434.At 0°C, a solution of N-benzyl-3-diazoindole (1.50g, 6.0mmol) in 1,2-dichloroethane (12mL) was slowly dropped into m-benzene over 60 minutes Dimethyl ether (30mmol) and trifluoromethanesulfonic acid (106uL, 20mol%) in 1,2-dichloroethane (10mL) solution, while vigorously stirring. After the dropwise addition was completed, stirring was continued at room temperature for 60 minutes until the 3-diazoindole was completely consumed. Then, excess NaHCO3 solid was added to the reaction solution to quench the reaction, the solid was filtered off and the solvent was removed under reduced pressure; the crude product was subjected to column chromatography (ethyl acetate:petroleum ether=1:30~1:10) to obtain Pure product N-benzyl-3-(2,4-dimethoxyphenyl)oxindole (1.94 g, 90%). 1 H NMR (CDCl 3 , 400MHz): δ7.39–7.24(m,5H), 7.15–7.11(m,1H), 7.04–7.02(m,2H), 6.04–6.90(m,1H), 6.74( d, J=7.8Hz 1H), 6.47–6.45(m, 2H), 5.10(d, J=15.6Hz 1H), 4.85(d, J=15.6Hz 1H), 4.82(s, 1H), 3.78(s ,3H),3.59(s,3H). 13 C NMR(100MHz,CDCl 3 ):δ177.0,160.6,158.5,143.3,136.3,130.9,130.1,128.7,127.6,127.6,127.5,124.0,122.4,118.2,108.7 . .HRMS(ESI): calcd for C 23 H 21 NNaO 3 [M+Na] + =382.1419, found 382.1434.
实施例16Example 16
在0℃下,将N-苄基-3-重氮氧化吲哚(1.50g,6.0mmol)的1,2-二氯乙烷(12mL)溶液用60分钟的时间缓缓滴入到均三甲苯(30mmol)和三氟甲磺酸(106uL,20mol%)的1,2-二氯乙烷(10mL)溶液中,同时剧烈搅拌。滴加完毕后,室温下继续搅拌60分钟,直至3-重氮氧化吲哚消耗完全。然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(乙酸乙酯:石油醚=1:30~1:10)得到纯产品N-苄基-3-(2,4,6-三甲基苯基)氧化吲哚(1.80g,88%)。1H NMR(CDCl3,400MHz):δ7.40(d,J=7.2Hz2H),7.33–7.30(m,1H),7.27–7.24(m,1H),7.19–7.15(m,1H),6.96–6.93(m,3H),6.82(d,J=7.8Hz 2H),6.75(s,1H),5.08(s,1H),5.06(d,J=15.4Hz 1H),4.91(d,J=15.4Hz 1H),2.52(s,3H),2.25(s,3H),1.60(s,3H).13C NMR(100MHz,CDCl3):δ176.5,143.2,137.9,137.1,137.0,136.1,130.5,130.3,129.1,128.8,127.9,127.80,127.7,123.7,122.7,108.8,48.2,44.3,21.3,20.9,19.3.FTIR(KBr):3426,3055,2922,1723,1611,1485,1465,1351,1199,1164,1096,1011,922,885,859,748,727,697cm-1.HRMS(ESI):calcd forC24H24NO[M+H]+=342.1858,found342.1861.At 0°C, a solution of N-benzyl-3-diazoindole (1.50g, 6.0mmol) in 1,2-dichloroethane (12mL) was slowly added dropwise to the H3 Toluene (30mmol) and trifluoromethanesulfonic acid (106uL, 20mol%) in 1,2-dichloroethane (10mL) solution, while vigorously stirring. After the dropwise addition was completed, stirring was continued at room temperature for 60 minutes until the 3-diazoindole was completely consumed. Then, excess NaHCO3 solid was added to the reaction solution to quench the reaction, the solid was filtered off and the solvent was removed under reduced pressure; the crude product was subjected to column chromatography (ethyl acetate:petroleum ether=1:30~1:10) to obtain Pure product N-benzyl-3-(2,4,6-trimethylphenyl)oxindole (1.80 g, 88%). 1 H NMR(CDCl 3 ,400MHz):δ7.40(d,J=7.2Hz2H),7.33–7.30(m,1H),7.27–7.24(m,1H),7.19–7.15(m,1H),6.96 –6.93(m,3H),6.82(d,J=7.8Hz 2H),6.75(s,1H),5.08(s,1H),5.06(d,J=15.4Hz 1H),4.91(d,J= 15.4Hz 1H), 2.52(s, 3H), 2.25(s, 3H), 1.60(s, 3H). 13 C NMR (100MHz, CDCl 3 ): δ176.5, 143.2, 137.9, 137.1, 137.0, 136.1, 130.5, 130.3, 129.1, 128.8, 127.9, 127.80, 127.7, 123.7, 122.7, 108.8, 48.2, 44.3, 21.3, 20.9, 19.3. FTIR (KBr): 3426, 3055, 2922, 1723, 1611, 1485, 1465, 1995 ,1164,1096,1011,922,885,859,748,727,697cm -1 .HRMS(ESI):calcd for C 24 H 24 NO[M+H] + =342.1858,found342.1861.
实施例17Example 17
在0℃下,将N-苄基-3-重氮氧化吲哚(1.50g,6.0mmol)的甲苯(12mL)溶液用60分钟的时间缓缓滴入到甲苯(10mL)和甲烷磺酸(100mol%)的混合溶液中,同时剧烈搅拌。滴加完毕后,室温下继续搅拌60分钟,直至3-重氮氧化吲哚消耗完全。然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(乙酸乙酯:石油醚=1:30~1:10)得到纯产品N-苄基-3-(对甲苯基)氧化吲哚(1.10g,77%)。At 0°C, a solution of N-benzyl-3-diazoxindole (1.50 g, 6.0 mmol) in toluene (12 mL) was slowly dropped into toluene (10 mL) and methanesulfonic acid ( 100mol%) in the mixed solution while vigorously stirring. After the dropwise addition was completed, stirring was continued at room temperature for 60 minutes until the 3-diazoindole was completely consumed. Then, excess NaHCO3 solid was added to the reaction solution to quench the reaction, the solid was filtered off and the solvent was removed under reduced pressure; the crude product was subjected to column chromatography (ethyl acetate:petroleum ether=1:30~1:10) to obtain Pure product N-benzyl-3-(p-tolyl)oxindole (1.10 g, 77%).
实施例18Example 18
在0℃下,将N-苄基-3-重氮氧化吲哚(1.50g,6.0mmol)的甲苯(12mL)溶液用60分钟的时间缓缓滴入到甲苯(10mL)和高氯酸(50mol%)的混合溶液中,同时剧烈搅拌。滴加完毕后,室温下继续搅拌60分钟,直至3-重氮氧化吲哚消耗完全。然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(乙酸乙酯:石油醚=1:30~1:10)得到纯产品N-苄基-3-(对甲苯基)氧化吲哚(1.18g,83%)。At 0°C, a solution of N-benzyl-3-diazoindole (1.50 g, 6.0 mmol) in toluene (12 mL) was slowly dropped into toluene (10 mL) and perchloric acid ( 50mol%) in the mixed solution while vigorously stirring. After the dropwise addition was completed, stirring was continued at room temperature for 60 minutes until the 3-diazoindole was completely consumed. Then, excess NaHCO3 solid was added to the reaction solution to quench the reaction, the solid was filtered off and the solvent was removed under reduced pressure; the crude product was subjected to column chromatography (ethyl acetate:petroleum ether=1:30~1:10) to obtain Pure product N-benzyl-3-(p-tolyl)oxindole (1.18 g, 83%).
实施例19Example 19
在0℃下,将N-苄基-3-重氮氧化吲哚(1.50g,6.0mmol)的甲苯(12mL)溶液用60分钟的时间缓缓滴入到甲苯(10mL)和氟硼酸(50mol%)的混合溶液中,同时剧烈搅拌。滴加完毕后,室温下继续搅拌60分钟,直至3-重氮氧化吲哚消耗完全。然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(乙酸乙酯:石油醚=1:30~1:10)得到纯产品N-苄基-3-(对甲苯基)氧化吲哚(1.02g,72%)。At 0°C, a solution of N-benzyl-3-diazoindole (1.50g, 6.0mmol) in toluene (12mL) was slowly dropped into toluene (10mL) and fluoroboric acid (50mol %) in the mixed solution while stirring vigorously. After the dropwise addition was completed, stirring was continued at room temperature for 60 minutes until the 3-diazoindole was completely consumed. Then, excess NaHCO3 solid was added to the reaction solution to quench the reaction, the solid was filtered off and the solvent was removed under reduced pressure; the crude product was subjected to column chromatography (ethyl acetate:petroleum ether=1:30~1:10) to obtain Pure product N-benzyl-3-(p-tolyl)oxindole (1.02 g, 72%).
实施例20Example 20
在0℃下,将N-苄基-3-重氮氧化吲哚(1.50g,6.0mmol)的环己烷(12mL)溶液用60分钟的时间缓缓滴入到甲苯(30mmol)和三氟甲磺酸(53uL,10mol%)的环己烷(10mL)溶液中,同时剧烈搅拌。滴加完毕后,室温下继续搅拌60分钟,直至3-重氮氧化吲哚消耗完全。然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(乙酸乙酯:石油醚=1:30~1:10)得到纯产品N-苄基-3-(对甲苯基)氧化吲哚(0.95g,67%)。At 0°C, a cyclohexane (12 mL) solution of N-benzyl-3-diazoindole (1.50 g, 6.0 mmol) was slowly dropped into toluene (30 mmol) and trifluoro Methanesulfonic acid (53uL, 10mol%) in cyclohexane (10mL) solution, while vigorously stirring. After the dropwise addition was completed, stirring was continued at room temperature for 60 minutes until the 3-diazoindole was completely consumed. Then, excess NaHCO3 solid was added to the reaction solution to quench the reaction, the solid was filtered off and the solvent was removed under reduced pressure; the crude product was subjected to column chromatography (ethyl acetate:petroleum ether=1:30~1:10) to obtain Pure product N-benzyl-3-(p-tolyl)oxindole (0.95 g, 67%).
实施例21Example 21
在0℃下,将6-三氟甲基-3-重氮氧化吲哚(1.36g,6.0mmol)的1,2-二氯乙烷(15mL)溶液用60分钟的时间缓缓滴入到4-氯苯甲醚(30mmol)和三氟甲磺酸(106uL,20mol%)的1,2-二氯乙烷(12mL)溶液中,同时剧烈搅拌。滴加完毕后,室温下继续搅拌60分钟,直至6-三氟甲基-3-重氮氧化吲哚消耗完全。然后向反应液中加入过量NaHCO3固体以淬灭反应,滤除固体并在减压下除去溶剂;将粗产物进行柱层析(乙酸乙酯:石油醚=1:10~1:4)得到纯产品6-三氟甲基-3-(2-甲氧基-5-氯苯基)氧化吲哚(1.23g,60%)。1H-NMR(400MHz,d6-DMSO):δ10.79(s,1H),7.34–7.37(m,2H),7.22(d,J=7.1Hz,1H)7.06–7.10(m,2H),7.02(d,J=8.8Hz,1H),4.92(s,1H),3.57(s,3H).13C NMR(100MHz,d6-DMSO):δ176.7,156.1,143.6,134.4,130.6,128.7,128.6(q),127.4,126.0,124.2,122.4,118.3,113.6,105.1,56.1,48.3.FTIR(KBr):3200,1710,1320,1250,1170,1120,1050cm-1.At 0°C, a solution of 6-trifluoromethyl-3-diazoindole (1.36g, 6.0mmol) in 1,2-dichloroethane (15mL) was slowly dropped into the 4-Chloroanisole (30mmol) and trifluoromethanesulfonic acid (106uL, 20mol%) in 1,2-dichloroethane (12mL) solution, while stirring vigorously. After the dropwise addition was completed, stirring was continued at room temperature for 60 minutes until 6-trifluoromethyl-3-diazoxindole was completely consumed. Then, excess NaHCO3 solid was added to the reaction solution to quench the reaction, the solid was filtered off and the solvent was removed under reduced pressure; the crude product was subjected to column chromatography (ethyl acetate:petroleum ether=1:10~1:4) to obtain Pure product 6-trifluoromethyl-3-(2-methoxy-5-chlorophenyl)oxindole (1.23 g, 60%). 1 H-NMR(400MHz,d 6 -DMSO):δ10.79(s,1H),7.34–7.37(m,2H),7.22(d,J=7.1Hz,1H)7.06–7.10(m,2H) , 7.02(d, J=8.8Hz, 1H), 4.92(s, 1H), 3.57(s, 3H). 13 C NMR (100MHz, d 6 -DMSO): δ176.7, 156.1, 143.6, 134.4, 130.6, 128.7 .
本实施例制备得到的6-三氟甲基-3-(2-甲氧基-5-氯苯基)氧化吲哚再经不对称氟代反应得到治疗脑中风的药物BMS-204352(MaxiPost),详细制备方法可参考文献:(a)Li,J.;Cai,Y.;Chen,W.;Liu,X.;Lin,L.;Feng,X.J.Org.Chem.,2012,77,9148–9155.;(b)Shibata,N.;Ishimaru,T.;Suzuki,E.;Kirk,K.L.J.Org.Chem.,2003,68,2494–2497.The 6-trifluoromethyl-3-(2-methoxy-5-chlorophenyl)oxindole prepared in this example is subjected to an asymmetric fluorination reaction to obtain the drug BMS-204352 (MaxiPost) for treating cerebral apoplexy , the detailed preparation method can refer to the literature: (a) Li, J.; Cai, Y.; Chen, W.; Liu, X.; Lin, L.; Feng, X.J.Org.Chem.,2012,77,9148– 9155.; (b) Shibata, N.; Ishimaru, T.; Suzuki, E.; Kirk, K.L.J.Org.Chem., 2003, 68, 2494–2497.
本发明的保护内容不局限于以上实施例。在不背离发明构思的精神和范围下,本领域技术人员能够想到的变化和优点都被包括在本发明中,并且以所附的权利要求书为保护范围。The protection content of the present invention is not limited to the above embodiments. Without departing from the spirit and scope of the inventive concept, changes and advantages conceivable by those skilled in the art are all included in the present invention, and the appended claims are the protection scope.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410205509.XA CN105085369B (en) | 2014-05-15 | 2014-05-15 | A kind of aryl oxidized indole derivatives of 3- and its synthetic method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410205509.XA CN105085369B (en) | 2014-05-15 | 2014-05-15 | A kind of aryl oxidized indole derivatives of 3- and its synthetic method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105085369A CN105085369A (en) | 2015-11-25 |
CN105085369B true CN105085369B (en) | 2018-04-24 |
Family
ID=54566798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410205509.XA Active CN105085369B (en) | 2014-05-15 | 2014-05-15 | A kind of aryl oxidized indole derivatives of 3- and its synthetic method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105085369B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110183423A (en) * | 2019-07-09 | 2019-08-30 | 四川大学 | A kind of new method activating synthesis 3- aryl Isatine derivatives by C-H using isatin diazonium as Cabbeen donor |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103274987A (en) * | 2013-06-07 | 2013-09-04 | 华东师范大学 | 3,3-disubstituted oxoindole derivative, and synthetic method and application thereof |
-
2014
- 2014-05-15 CN CN201410205509.XA patent/CN105085369B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103274987A (en) * | 2013-06-07 | 2013-09-04 | 华东师范大学 | 3,3-disubstituted oxoindole derivative, and synthetic method and application thereof |
Non-Patent Citations (2)
Title |
---|
Highly enantioselective fluorination of unprotected 3-substituted oxindoles: one-step synthesis of BMS 204352 (MaxiPost);Jun Li等;《J. Org. Chem.》;20121002;第77卷;第9150页表4 * |
Highly site-selective direct C-H bond functionalization of phenols with α-aryl-α-diazoacetates and diazooxindoles via gold catalysis;Zhunzhun Yu等;《J. Am. Chem. Soc.》;20140429;第136卷;第6905页方案2 * |
Also Published As
Publication number | Publication date |
---|---|
CN105085369A (en) | 2015-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Syu et al. | Preparation of functional benzofurans, benzothiophenes, and indoles using ester, thioester, and amide via intramolecular wittig reactions | |
Han et al. | Synthesis of tetraphenylene derivatives and their recent advances | |
CN107935812B (en) | Method for preparing polyaryl substituted naphthalene derivative by reaction of alkyl aryl ketone and tolane under catalysis of ruthenium | |
Ogawa et al. | Synthesis of π-extended fluoranthenes via a KHMDS-promoted anionic-radical reaction cascade | |
CN105085369B (en) | A kind of aryl oxidized indole derivatives of 3- and its synthetic method | |
CN102942511B (en) | A kind of preparation method of cyclopentadiene | |
CN108640917A (en) | A kind of synthetic method of indoles simultaneously [2,1-a] isoquinoline compound | |
CN108610278B (en) | Synthetic method of 6-amino-5-acyl benzo [ a ] carbazole compound | |
CN108976243A (en) | Spiral shell-chroman -4,3 '-Oxoindole synthetic method is synthesized with the hydroxy-benzyl alcohol of neighbour containing Oxoindole by dimethyl furan | |
CN107805253B (en) | Chiral spiro-epoxy indole compounds and synthesis method thereof | |
CN102127002B (en) | Method for preparing 3,3-diaryl substituted and 3-alkyl-3-aryl substituted oxoindole derivative | |
CN110105274A (en) | A kind of synthetic method of 3- (2- aminoaryl) quinolines | |
CN112028872B (en) | A kind of synthetic method of dibenzoselenophene compound | |
CN109503547A (en) | The preparation method of two sulphur cyclopentadiene derivant of benzo | |
CN112939844B (en) | A kind of multi-substituted tetrahydrocarbazole and its derivatives and its synthesis method and application | |
Zhang et al. | Palladium-Catalyzed Tandem Carbocyclization and Hetroarylation for the Synthesis of 2-(Trifluoromethyl) indenylmethyleneindoles | |
CN106866496B (en) | Hexahydrobenzoquinolin-6-one and hexahydrobenzindol-5-one compound, synthesis method and use | |
CN108276420B (en) | A kind of 8,13-dihydrobenzo[5,6]chromeno[2,3-b]indole compound and its synthesis method | |
CN113443987B (en) | Method for constructing chiral tetra-substituted exocyclic alpha-hydroxy allenoic acid ester through asymmetric catalysis of copper | |
CN115197087B (en) | Polysubstituted cyclobutene derivatives and preparation methods thereof | |
CN113651755B (en) | A kind of 4-azafluorene compound and its preparation method and application | |
CN105237459B (en) | One-step synthesis 2-sulfonyl replaces the method for 1-isoindolinone compounds | |
CN104557827B (en) | 3-quaternary carbon chirality-C-acyl group benzofuranone derivatives and preparation method thereof | |
CN109053754B (en) | Synthetic method for constructing polysubstituted chroman compound based on biomass source 2, 5-dimethylfuran dearomatization cycloaddition strategy | |
CN103396314B (en) | Synthetic method of fullerene cyclopropane derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190123 Address after: 528437 Zone C, 13th Floor, No. 1 Health Road, Torch Development Zone, Zhongshan City, Guangzhou City, Guangdong Province Patentee after: Guangdong and Bo Pharmaceutical Co., Ltd. Address before: 200062 Zhongshan North Road, Putuo District, Shanghai, No. 3663 Patentee before: East China Normal University |